Avalo Therapeutics (AVTX) EBT Margin Growth (3y) (2019 - 2025)
Avalo Therapeutics (AVTX) EBT Margin Growth (3y) (2019 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 9,237.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 441.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -408.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 363.00 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Avalo Therapeutics | 1.04 Mn | 1.04 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -2.19 Mn |
| Dec 31, 2024 | -960,343.00 |
| Sep 30, 2024 | 1.05 Mn |
| Dec 31, 2023 | -34,133.00 |
| Sep 30, 2023 | -101,853.00 |
| Jun 30, 2023 | -28,057.00 |
| Mar 31, 2023 | -121,132.00 |
| Dec 31, 2022 | -95,261.00 |
| Sep 30, 2022 | 14,899.00 |
| Jun 30, 2022 | -107,882.00 |
| Mar 31, 2022 | -168,381.00 |
| Dec 31, 2021 | -875,752.00 |
| Sep 30, 2021 | -69,107.00 |
| Jun 30, 2021 | -39,262.00 |
| Mar 31, 2021 | -637,543.00 |
| Dec 31, 2020 | -86,282.00 |
| Sep 30, 2020 | -128,101.00 |
| Jun 30, 2020 | 14,722.00 |
| Mar 31, 2020 | -37,248.00 |
| Dec 31, 2019 | 75,880.00 |